Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis

Cell Host and Microbe

Volumn 21, Issue 4, 2017, Pages 478-493.e7

  Zhu, Feng ^a   Willette Brown, Jami ^a   Song, Na Young ^a   Lomada, Dakshayani ^b   Song, Yongmei ^c   Xue, Liyan ^d   Gray, Zane ^a   Zhao, Zitong ^c   Davis, Sean R ^e   Sun, Zhonghe ^f   Zhang, Peilin ^g   Wu, Xiaolin ^f   Zhan, Qimin ^c   Richie, Ellen R ^b   Hu, Yinling ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CANCER HOSPITAL   (China)

^d PEKING UNION MEDICAL COLLEGE   (China)

^e NATIONAL CANCER INSTITUTE   (United States)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^g PZM Diagnostics LLC LLC   (United States)

Author keywords

autoimmune disease; autoreactive T cells; EGFR; esophageal squamous cell carcinoma; fungal infection; IKKalpha; inflammation; mucosal epithelium

Indexed keywords

AMPHOTERICIN B; EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B KINASE ALPHA; TUMOR MARKER; EGFR PROTEIN, MOUSE;

ANIMAL TISSUE; ANTIFUNGAL THERAPY; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CANCER PREVENTION; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MOUSE; MYCOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T CELL DEPLETION; TISSUE INJURY; ANIMAL; AUTOIMMUNITY; CANDIDIASIS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; DISEASE MODEL; ESOPHAGEAL NEOPLASMS; IMMUNOLOGY; METABOLISM; PATHOLOGY; POLYENDOCRINOPATHY;

ANIMALS; AUTOIMMUNITY; CANDIDIASIS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ESOPHAGEAL NEOPLASMS; MICE; POLYENDOCRINOPATHIES, AUTOIMMUNE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 85017333200     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.03.006     Document Type: Article

References (49)

1. Akiyama, T., Maeda, S., Yamane, S., Ogino, K., Kasai, M., Kajiura, F., Matsumoto, M., Inoue, J., Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 308 (2005), 248–251.
2. Akiyama, T., Shimo, Y., Yanai, H., Qin, J., Ohshima, D., Maruyama, Y., Asaumi, Y., Kitazawa, J., Takayanagi, H., Penninger, J.M., et al. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29 (2008), 423–437.
3. Anderson, M.S., Venanzi, E.S., Klein, L., Chen, Z., Berzins, S.P., Turley, S.J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., Mathis, D., Projection of an immunological self shadow within the thymus by the aire protein. Science 298 (2002), 1395–1401.
4. Beerli, R.R., Bauer, M., Fritzer, A., Rosen, L.B., Buser, R.B., Hanner, M., Maudrich, M., Nebenfuehr, M., Toepfer, J.A., Mangold, S., et al. Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma. MAbs 6 (2014), 1608–1620.
5. Cao, Y., Bonizzi, G., Seagroves, T.N., Greten, F.R., Johnson, R., Schmidt, E.V., Karin, M., IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107 (2001), 763–775.
6. Chang, H.C., Leaw, S.N., Huang, A.H., Wu, T.L., Chang, T.C., Rapid identification of yeasts in positive blood cultures by a multiplex PCR method. J. Clin. Microbiol. 39 (2001), 3466–3471.
7. Chen, L., Deng, H., Lu, M., Xu, B., Wang, Q., Jiang, J., Wu, C., B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer. Int. J. Clin. Exp. Pathol. 7 (2014), 6015–6023.
8. Conti, H.R., Shen, F., Nayyar, N., Stocum, E., Sun, J.N., Lindemann, M.J., Ho, A.W., Hai, J.H., Yu, J.J., Jung, J.W., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206 (2009), 299–311.
9. Coste, A., Lagane, C., Filipe, C., Authier, H., Galès, A., Bernad, J., Douin-Echinard, V., Lepert, J.C., Balard, P., Linas, M.D., et al. IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation. J. Immunol. 180 (2008), 4939–4947.
10. Descargues, P., Sil, A.K., Sano, Y., Korchynskyi, O., Han, G., Owens, P., Wang, X.J., Karin, M., IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc. Natl. Acad. Sci. USA 105 (2008), 2487–2492.
11. Ferrer, C., Colom, F., Frasés, S., Mulet, E., Abad, J.L., Alió, J.L., Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J. Clin. Microbiol. 39 (2001), 2873–2879.
12. Ghannoum, M.A., Jurevic, R.J., Mukherjee, P.K., Cui, F., Sikaroodi, M., Naqvi, A., Gillevet, P.M., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog., 6, 2010, e1000713.
13. Gordon, K.B., Blauvelt, A., Papp, K.A., Langley, R.G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S.G., Braun, D.K., et al. UNCOVER-1 Study Group UNCOVER-2 Study Group, UNCOVER-3 Study Group. Phase 3 trials of Ixekizumab in moderate-to-severe plaque psoriasis. N. Engl. J. Med. 375 (2016), 345–356.
14. Hamazaki, Y., Fujita, H., Kobayashi, T., Choi, Y., Scott, H.S., Matsumoto, M., Minato, N., Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat. Immunol. 8 (2007), 304–311.
15. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., Karin, M., Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284 (1999), 316–320.
16. Hu, Y., Baud, V., Oga, T., Kim, K.I., Yoshida, K., Karin, M., IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410 (2001), 710–714.
17. Jiang, Q., Weiss, J.M., Back, T., Chan, T., Ortaldo, J.R., Guichard, S., Wiltrout, R.H., mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment. Cancer Res. 71 (2011), 4074–4084.
18. Kogawa, K., Kudoh, J., Nagafuchi, S., Ohga, S., Katsuta, H., Ishibashi, H., Harada, M., Hara, T., Shimizu, N., Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations. Clin. Immunol. 103 (2002), 277–283.
19. Li, L., Ruan, Q., Hilliard, B., Devirgiliis, J., Karin, M., Chen, Y.H., Transcriptional regulation of the Th17 immune response by IKK(alpha). J. Exp. Med. 208 (2011), 787–796.
20. Lin, G., Sun, X.J., Han, Q.B., Wang, Z., Xu, Y.P., Gu, J.L., Wu, W., Zhang, G.U., Hu, J.L., Sun, W.Y., Mao, W.M., Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma. Oncol. Lett. 10 (2015), 901–906.
21. Liu, B., Park, E., Zhu, F., Bustos, T., Liu, J., Shen, J., Fischer, S.M., Hu, Y., A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc. Natl. Acad. Sci. USA 103 (2006), 17202–17207.
22. Liu, B., Xia, X., Zhu, F., Park, E., Carbajal, S., Kiguchi, K., DiGiovanni, J., Fischer, S.M., Hu, Y., IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell 14 (2008), 212–225.
23. Liu, B., Willette-Brown, J., Liu, S., Chen, X., Fischer, S.M., Hu, Y., IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin. Cell Death Differ. 18 (2011), 1854–1864.
24. Lomada, D., Liu, B., Coghlan, L., Hu, Y., Richie, E.R., Thymus medulla formation and central tolerance are restored in IKKalpha-/- mice that express an IKKalpha transgene in keratin 5+ thymic epithelial cells. J. Immunol. 178 (2007), 829–837.
25. Maeda, G., Chiba, T., Kawashiri, S., Satoh, T., Imai, K., Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression. Clin. Cancer Res. 13 (2007), 5041–5047.
26. Manley, N.R., Richie, E.R., Blackburn, C.C., Condie, B.G., Sage, J., Structure and function of the thymic microenvironment. Front. Biosci. (Landmark Ed.) 16 (2011), 2461–2477.
27. Marinari, B., Moretti, F., Botti, E., Giustizieri, M.L., Descargues, P., Giunta, A., Stolfi, C., Ballaro, C., Papoutsaki, M., Alemà, S., et al. The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway. Proc. Natl. Acad. Sci. USA 105 (2008), 17091–17096.
28. Mathis, D., Benoist, C., Aire. Annu. Rev. Immunol. 27 (2009), 287–312.
29. Mermel, L.A., Allon, M., Bouza, E., Craven, D.E., Flynn, P., O'Grady, N.P., Raad, I.I., Rijnders, B.J., Sherertz, R.J., Warren, D.K., Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49 (2009), 1–45.
30. Niemi, H.J., Laakso, S., Salminen, J.T., Arstila, T.P., Tuulasvaara, A., A normal T cell receptor beta CDR3 length distribution in patients with APECED. Cell. Immunol. 295 (2015), 99–104.
31. Ostanin, D.V., Barlow, S., Shukla, D., Grisham, M.B., NADPH oxidase but not myeloperoxidase protects lymphopenic mice from spontaneous infections. Biochem. Biophys. Res. Commun. 355 (2007), 801–806.
32. Park, E., Zhu, F., Liu, B., Xia, X., Shen, J., Bustos, T., Fischer, S.M., Hu, Y., Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res. 67 (2007), 9158–9168.
33. Polack, F.M., Siverio, C., Bresky, R.H., Corneal chromomycosis: double infection by Phialophora verrucosa (Medlar) and Cladosporium cladosporioides (Frescenius). Ann. Ophthalmol. 8 (1976), 139–144.
34. Puel, A., Cypowyj, S., Bustamante, J., Wright, J.F., Liu, L., Lim, H.K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332 (2011), 65–68.
35. Ramsey, C., Winqvist, O., Puhakka, L., Halonen, M., Moro, A., Kämpe, O., Eskelin, P., Pelto-Huikko, M., Peltonen, L., Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11 (2002), 397–409.
36. Rautemaa, R., Hietanen, J., Niissalo, S., Pirinen, S., Perheentupa, J., Oral and oesophageal squamous cell carcinoma–a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol. 43 (2007), 607–613.
37. Ryan, K.R., Hong, M., Arkwright, P.D., Gennery, A.R., Costigan, C., Dominguez, M., Denning, D., McConnell, V., Cant, A.J., Abinun, M., et al. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin. Exp. Immunol. 154 (2008), 406–414.
38. Song, Y., Li, L., Ou, Y., Gao, Z., Li, E., Li, X., Zhang, W., Wang, J., Xu, L., Zhou, Y., et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509 (2014), 91–95.
39. Stoner, G.D., Gupta, A., Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22 (2001), 1737–1746.
40. Underhill, D.M., Iliev, I.D., The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14 (2014), 405–416.
41. van de Veerdonk, F.L., Joosten, L.A., Shaw, P.J., Smeekens, S.P., Malireddi, R.K., van der Meer, J.W., Kullberg, B.J., Netea, M.G., Kanneganti, T.D., The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur. J. Immunol. 41 (2011), 2260–2268.
42. Wettstein, P., Strausbauch, M., Therneau, T., Borson, N., The application of real-time PCR to the analysis of T cell repertoires. Nucleic Acids Res., 36, 2008, e140.
43. Xia, X., Park, E., Liu, B., Willette-Brown, J., Gong, W., Wang, J., Mitchell, D., Fischer, S.M., Hu, Y., Reduction of IKKalpha expression promotes chronic ultraviolet B exposure-induced skin inflammation and carcinogenesis. Am. J. Pathol. 176 (2010), 2500–2508.
44. Xia, X., Liu, S., Xiao, Z., Zhu, F., Song, N.Y., Zhou, M., Liu, B., Shen, J., Nagashima, K., Veenstra, T.D., et al. An IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity. Cell Rep. 5 (2013), 1243–1255.
45. Xiao, Z., Jiang, Q., Willette-Brown, J., Xi, S., Zhu, F., Burkett, S., Back, T., Song, N.Y., Datla, M., Sun, Z., et al. The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 23 (2013), 527–540.
46. Yan, M., Zhang, Y., He, B., Xiang, J., Wang, Z.F., Zheng, F.M., Xu, J., Chen, M.Y., Zhu, Y.L., Wen, H.J., et al. IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation. Nat. Commun., 5, 2014, 3661.
47. Zhu, F., Xia, X., Liu, B., Shen, J., Hu, Y., Person, M., Hu, Y., IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Mol. Cell 27 (2007), 214–227.
48. Zhu, W., Phan, Q.T., Boontheung, P., Solis, N.V., Loo, J.A., Filler, S.G., EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc. Natl. Acad. Sci. USA 109 (2012), 14194–14199.
49. Zimmermann, K.C., Sarbia, M., Weber, A.A., Borchard, F., Gabbert, H.E., Schrör, K., Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59 (1999), 198–204.